Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999-2016

Jacqueline T Vuong1, Sophia A Jacob2, Kevin M Alexander3

  • 1Boston University School of Medicine, Boston, Massachusetts.

Journal of Cardiac Failure
|November 25, 2018
PubMed

Insights

Heart failure and dementia disproportionately affect older adults, whites, and women, contributing significantly to nationwide mortality. Understanding these trends is crucial for public health strategies targeting aging populations.

Area of Science:

  • Gerontology and Public Health
  • Epidemiology of Chronic Diseases

Background:

  • Heart failure and dementia are leading causes of morbidity and mortality in the elderly.
  • Shared risk factors suggest a complex interplay between these conditions.
  • Significant healthcare expenditures underscore the need to understand their combined impact.

Purpose of the Study:

  • To estimate the national mortality burden attributed to heart failure and dementia.
  • To characterize the demographic profiles of individuals impacted by these conditions.

Main Methods:

  • Retrospective analysis of National Vital Statistics Data (1999-2016).
  • Utilized International Classification of Diseases (10th edition) codes for heart failure and dementia.
  • Data sourced from the Centers for Disease Control and Medicare Chronic Conditions Data Warehouse.

Main Results:

  • Over 214,000 deaths involved both heart failure and dementia (4% of HF deaths, 9% of dementia deaths).
  • Higher age-adjusted mortality rates observed in women and White individuals.
  • Under age 65, men exhibited higher crude mortality rates than women.

Conclusions:

  • The study highlights significant mortality contributions from combined heart failure and dementia.
  • Populations over 85 years, White individuals, and women bear a disproportionate burden.
  • Findings inform public health initiatives for aging populations and chronic disease management.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
933
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
888
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
339
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
968
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
316